3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
57
Recurrence
7
Neoplasms, Plasma Cell
6
Lymphoma
6
Immunoglobulin Light-chain Amyloidosis
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Paraproteinemias
2
Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Acute
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thalassemia
1
Sarcoma, Myeloid
1
Renal Insufficiency
1
Prostatic Neoplasms
1
Plasmablastic Lymphoma
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
lanreotide
1
fluorodopa F 18
1
cabozantinib
1
Sunitinib
1
Random Allocation
1
Octreotide
1
Nivolumab
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoid Tumor
×
Bortezomib
×
90 days
×
Clear all
No trials found.